Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Johannes Czernin
University of California Los Angeles, Department: Pharmacology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Sofie Biosciences
Intellectual property rights (e.g., royalties, patents, copyrights) not from the awardee Institution
Professor Czernin will oversee the preclinical imaging studies under Aims 1 and 2, and the clinical imaging studies outlined in Aim 2. He is a founder of Sofie, on the BOD, and an inventor of IP to be used in this study.
PET Imaging-guided Personalized Therapy in Pancreatic Cancer
Oncologists now face the challenging decision of how to best treat pancreatic cancer given the recent FDA approval of the gemcitabine/Abraxane combination and the emergence of new chemotherapeutic regimens. To address this unmet clinical need and enable a more personalized approach to pancreatic cancer treatment, we will develop a new non-invasive companion biomarker to gemcitabine/Abraxane which will allow the identification of patients who are likely responders to this combination at the beginning of their therapy.
Filed on September 25, 2014.
Tell us what you know about Johannes Czernin's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Johannes Czernin filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Johannes Czernin | University of California Los Angeles | Conflict of Interest | Sofie Biosciences | $150,000 - $199,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.